A Phase I Study of Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
Conditions: Recurrent Respiratory Papillomatosis; Papillomavirus Infections; Papillomaviridae Intervention: Drug: PRGN-2012 Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials